HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Detemir

TERMINATED · PHASE4 · Diabetes Mellitus, Type 2

No documentation with MHRA to support clinical trial of a medicinal product.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.